Loading…
Curis Lifesciences (CURIS)₹179.65−2.26%Pharmaceuticals
Curis Lifesciences is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 21.0 against a peer median of 14.0, and ROCE of 21.2% against a peer median of 17.0%, and latest-quarter sales growth of −4.8% against a peer median of 9.5%. By market cap it is #3 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Medico Remedies | 157 | 11.6 | 23.1 | 18.9 | 0.25 | 0.0 | 206 | 13 | 37.4 | 34.9 | vs CURIS |
| Natural Capsules | 153 | — | −5.0 | −9.5 | 0.92 | 0.0 | 188 | −25 | 7.7 | — | vs CURIS |
| Curis Lifesciences | 146 | 21.0 | 21.2 | 21.7 | 0.46 | 0.0 | 61 | 7 | −4.8 | −32.2 | — |
| Sotac Pharmaceuticals | 143 | 25.0 | 13.1 | 10.3 | 0.64 | 0.1 | 101 | 6 | 27.6 | −50.0 | vs CURIS |
| Kimia Biosciences | 142 | 19.2 | 25.0 | 53.6 | 1.97 | 0.0 | 115 | 7 | −12.1 | −39.3 | vs CURIS |
| Auro Laboratories | 142 | 40.4 | 9.5 | 8.5 | 1.36 | 0.0 | 31 | 4 | 32.7 | 152.6 | vs CURIS |
| Quest Laboratories | 142 | 9.5 | 17.9 | 16.8 | 0.08 | 0.0 | 112 | 15 | −30.3 | 48.2 | vs CURIS |
| Panchsheel Organics | 141 | 13.0 | 10.0 | 7.9 | 0.04 | 3.0 | 107 | 11 | 9.5 | −46.5 | vs CURIS |
| Par Drugs and Chemicals | 139 | 9.6 | 17.0 | 12.4 | 0.00 | 0.0 | 104 | 13 | 20.2 | 41.6 | vs CURIS |
| Speciality Medicines | 136 | 10.4 | 25.0 | 25.5 | 0.09 | 0.0 | 75 | 13 | 45.2 | 166.1 | vs CURIS |
| Parnax Lab | 134 | 15.0 | 14.0 | 14.4 | 0.87 | 0.0 | 249 | 12 | 6.4 | −86.6 | vs CURIS |
| Peer median | 142 | 14.0 | 17.0 | 14.4 | 0.46 | 0.0 | 107 | 11 | 9.5 | 1.4 |
Listed companies closest to Curis Lifesciences in Pharmaceuticals include Medico Remedies, Natural Capsules, Sotac Pharmaceuticals, Kimia Biosciences, Auro Laboratories, Quest Laboratories, Panchsheel Organics, Par Drugs and Chemicals.
Medico Remedies, with a market cap of ₹157 Cr.
Curis Lifesciences trades at a P/E of 21.0; the median of its peer set is 14.0. A P/E above or below the median is a description, not a judgement on value.
Curis Lifesciences' return on capital employed is 21.2%, above the peer median of 17.0%.